MGR Foamtex tests successfully against Sars-Cov-2 with Biomaster Antimicrobial Technology

MGR Foamtex Ltd, world-leader in the design, development and manufacture of advanced passenger upholstery systems for Premium cabin seating, has announced that its advanced antimicrobial MGRSafeWall™ product protection system has been successfully tested against SARS-CoV-2, the virus that causes COVID-19, using Biomaster antimicrobial technology. Laboratory testing to ISO 18184 protocols using MGRSafeWall™ and real aircraft cabin products has demonstrated efficacy of 96.8% against SARS-CoV-2. In addition to the viral testing, MGRSafeWall™ has also shown excellent behaviour in flammability, abrasion and resistance to cleaning agent tests. The ability to facilitate commercial testing for efficacy against SARS-CoV-2 is a recent development as testing with the actual virus was previously only permitted in government facilities. Until now, all testing used a substitute envelope virus. Jon Rose, Managing Director of MGR Foamtex says: “This is truly exciting news for all of us in the industry. It is a real game-changer as we believe that this is the first time that real aircraft cabin materials have been tested with actual SARS-CoV-2.

Find out more about Addmaster (UK) Ltd on their member profile page here

Member-created content 4 months ago | Members' news

More News

Share this page: